SE0014428512
SE0014428512
Surgical Science Sweden AB
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.72B EUR | 1.62B EUR | 1.55B EUR | 1.66B EUR |
Enterprise Value | 2.07B EUR | 964.04M EUR | 884.6M EUR | 1.1B EUR |
Valuation Multiples | ||||
Trailing P/E | 29.34x | 17.39x | 29.69x | 49.39x |
Forward P/E | 10.97x | -- | -- | -- |
Price to Sales | 2.66x | 1.58x | 1.59x | 2.24x |
Price to Book | 0.6x | 0.36x | 0.35x | 0.39x |
EV/Revenue | 2.02x | 0.94x | 0.91x | 1.48x |
EV/EBITDA | 11.22x | 7.84x | 13.03x | 24.41x |
Price to FCF (P/FCF) | 90.33x | 19.44x | 16.59x | 35.97x |
EV/FCF | 68.6x | 11.57x | 9.47x | 23.83x |
FCF Yield | 1.11% | 5.14% | 6.03% | 2.78% |